The global stromal vascular fraction market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for stem cells in various applications such as regenerative medicine, drug discovery and development, and cell therapy.
The global stromal vascular fraction market is segmented on the basis of type into SVF isolation products, enzymatic isolation, noenzymatic isolation, automated POC devices and SVF aspirate purification products. The application segment includes hospitals and specialty clinics whereas the region segment includes North America, Latin America, Europe Asia Pacific and Middle East & Africa.
- Increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the global Stromal Vascular Fraction market.
- Increasing demand for minimally invasive procedures in healthcare facilities is also driving the growth of the global Stromal Vascular Fraction market.
- The increasing number of clinical trials on stem cells and regenerative medicine are also driving the growth of this market.
- The increasing number of research studies on stem cells and regenerative medicine are also driving this market.
Industry Growth Insights published a new data on “Stromal Vascular Fraction Market”. The research report is titled “Stromal Vascular Fraction Market research by Types (SVF Isolation Products, Enzymatic Isolation, Non-enzymatic Isolation, Automated POC Devices, SVF Aspirate Purification Products, SVF Transfer Products), By Applications (Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Others), By Players/Companies Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences, LifeCell”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stromal Vascular Fraction Market Research Report
By Type
SVF Isolation Products, Enzymatic Isolation, Non-enzymatic Isolation, Automated POC Devices, SVF Aspirate Purification Products, SVF Transfer Products
By Application
Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Others
By Companies
Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences, LifeCell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Stromal Vascular Fraction Market Report Segments:
The global Stromal Vascular Fraction market is segmented on the basis of:
Types
SVF Isolation Products, Enzymatic Isolation, Non-enzymatic Isolation, Automated POC Devices, SVF Aspirate Purification Products, SVF Transfer Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cytori Therapeutics
- GE Healthcare
- Ingeneron
- Medikan International
- Tissue Genesis
- Genesis Biosystems
- Human Med
- IntelliCell BioSciences
- LifeCell
Highlights of The Stromal Vascular Fraction Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SVF Isolation Products
- Enzymatic Isolation
- Non-enzymatic Isolation
- Automated POC Devices
- SVF Aspirate Purification Products
- SVF Transfer Products
- By Application:
- Hospitals
- Specialty Clinics
- Stem Cell Banks/Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stromal Vascular Fraction Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stromal vascular fraction (SVF) is a measure of the percentage of cells in a sample that are endothelial cells. Endothelial cells line the interior surface of blood vessels and play an important role in regulating blood flow.
Some of the major players in the stromal vascular fraction market are Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences, LifeCell.
The stromal vascular fraction market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stromal Vascular Fraction Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stromal Vascular Fraction Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stromal Vascular Fraction Market - Supply Chain
4.5. Global Stromal Vascular Fraction Market Forecast
4.5.1. Stromal Vascular Fraction Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stromal Vascular Fraction Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stromal Vascular Fraction Market Absolute $ Opportunity
5. Global Stromal Vascular Fraction Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stromal Vascular Fraction Market Size and Volume Forecast by Type
5.3.1. SVF Isolation Products
5.3.2. Enzymatic Isolation
5.3.3. Non-enzymatic Isolation
5.3.4. Automated POC Devices
5.3.5. SVF Aspirate Purification Products
5.3.6. SVF Transfer Products
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stromal Vascular Fraction Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stromal Vascular Fraction Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.3.3. Stem Cell Banks/Laboratories
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stromal Vascular Fraction Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stromal Vascular Fraction Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stromal Vascular Fraction Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stromal Vascular Fraction Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stromal Vascular Fraction Demand Share Forecast, 2019-2026
9. North America Stromal Vascular Fraction Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stromal Vascular Fraction Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stromal Vascular Fraction Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Specialty Clinics
9.4.3. Stem Cell Banks/Laboratories
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stromal Vascular Fraction Market Size and Volume Forecast by Type
9.7.1. SVF Isolation Products
9.7.2. Enzymatic Isolation
9.7.3. Non-enzymatic Isolation
9.7.4. Automated POC Devices
9.7.5. SVF Aspirate Purification Products
9.7.6. SVF Transfer Products
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stromal Vascular Fraction Demand Share Forecast, 2019-2026
10. Latin America Stromal Vascular Fraction Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stromal Vascular Fraction Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stromal Vascular Fraction Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Stem Cell Banks/Laboratories
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stromal Vascular Fraction Market Size and Volume Forecast by Type
10.7.1. SVF Isolation Products
10.7.2. Enzymatic Isolation
10.7.3. Non-enzymatic Isolation
10.7.4. Automated POC Devices
10.7.5. SVF Aspirate Purification Products
10.7.6. SVF Transfer Products
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stromal Vascular Fraction Demand Share Forecast, 2019-2026
11. Europe Stromal Vascular Fraction Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stromal Vascular Fraction Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stromal Vascular Fraction Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Stem Cell Banks/Laboratories
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stromal Vascular Fraction Market Size and Volume Forecast by Type
11.7.1. SVF Isolation Products
11.7.2. Enzymatic Isolation
11.7.3. Non-enzymatic Isolation
11.7.4. Automated POC Devices
11.7.5. SVF Aspirate Purification Products
11.7.6. SVF Transfer Products
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stromal Vascular Fraction Demand Share, 2019-2026
12. Asia Pacific Stromal Vascular Fraction Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stromal Vascular Fraction Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stromal Vascular Fraction Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Stem Cell Banks/Laboratories
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stromal Vascular Fraction Market Size and Volume Forecast by Type
12.7.1. SVF Isolation Products
12.7.2. Enzymatic Isolation
12.7.3. Non-enzymatic Isolation
12.7.4. Automated POC Devices
12.7.5. SVF Aspirate Purification Products
12.7.6. SVF Transfer Products
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stromal Vascular Fraction Demand Share, 2019-2026
13. Middle East & Africa Stromal Vascular Fraction Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stromal Vascular Fraction Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stromal Vascular Fraction Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Stem Cell Banks/Laboratories
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stromal Vascular Fraction Market Size and Volume Forecast by Type
13.7.1. SVF Isolation Products
13.7.2. Enzymatic Isolation
13.7.3. Non-enzymatic Isolation
13.7.4. Automated POC Devices
13.7.5. SVF Aspirate Purification Products
13.7.6. SVF Transfer Products
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stromal Vascular Fraction Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Stromal Vascular Fraction Market: Market Share Analysis
14.2. Stromal Vascular Fraction Distributors and Customers
14.3. Stromal Vascular Fraction Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cytori Therapeutics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ingeneron
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medikan International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tissue Genesis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Genesis Biosystems
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Human Med
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IntelliCell BioSciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LifeCell
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
